Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |